Embody vs Regenics: Low-price compounded GLP-1 options
Embody vs Regenics answers which telehealth GLP-1 option is best for cash-pay patients. Early verdict: Embody targets lowest entry price with $69/month semaglutide and 1 to 2 day shipping, while Regenics offers a higher promotional entry, clinician-led reviews by nurse practitioners, and a broader peptide add-on.
Quick comparison of the standout differences
This direct comparison focuses on the most distinctive supported differences: pricing and promotions, clinician oversight model, shipping speed and fulfillment, availability of additional therapies, and regulatory status of compounded drugs. Each point uses only supplied facts.
1. Pricing and promotional structure
Embody lists a starting price of $69/month for compounded semaglutide, cut from $299, and $119/month for compounded tirzepatide. Regenics lists semaglutide at $139 for the first month with renewal at $199, and tirzepatide at $189 first month with renewal at $279. The key difference is Embody presents a consistently low monthly price as its headline offer, while Regenics uses a lower first month price that renews higher.
See Regenics first month pricing
2. Clinician oversight and care model
Embody is described as a licensed telehealth platform with prescription and telemed visits included and a licensed provider review handled online. Regenics is described as nurse-practitioner-led care where licensed nurse practitioners review intake and oversee every prescription. Both use clinician review before prescribing, but Regenics specifically highlights nurse practitioner oversight and a clinician determination of medical appropriateness.
3. Shipping, fulfillment, and pharmacy notes
Embody advertises free shipping with delivery in 1 to 2 days after clinician approval. Regenics advertises free shipping with medication compounded in the USA and notes a LegitScript certified pharmacy network in the detailed description. Embody emphasizes speed of delivery while Regenics emphasizes U.S. compounding and pharmacy network certification.
4. Additional therapies and features
Embody focuses on compounded semaglutide and compounded tirzepatide at aggressive entry pricing and notes fewer premium features such as integrated coaching. Regenics offers compounded semaglutide and tirzepatide plus a Sermorelin peptide therapy as an add-on and lists FSA and HSA eligibility. Regenics also notes LegitScript certified pharmacy network. These are the primary product and feature distinctions available in the sources.
5. Regulatory and medication type
Both sources state their GLP-1 offerings are compounded medications and include the regulatory note that compounded medications are not FDA approved finished products and are not reviewed by FDA for safety, effectiveness or quality. Embody explicitly clarifies that its medications are compounded and not FDA approved finished products while using the same active ingredients as branded options. Regenics similarly notes compounded medications are not FDA approved and that treatment is available only when a licensed clinician determines it is clinically appropriate.
Comparison table: Embody vs Regenics
| Criteria | Embody | Regenics |
|---|---|---|
| Starting semaglutide price | $69/month for compounded semaglutide (was $299) | $139 first month; renews $199/month |
| Tirzepatide price | $119/month compounded tirzepatide | $189 first month; renews $279/month |
| Clinician oversight | Licensed provider review handled online | Licensed nurse practitioners review intake and oversee prescriptions |
| Shipping and fulfillment | Free shipping; arrives in 1 to 2 days after approval | Free shipping; compounded in the USA; LegitScript certified pharmacy network |
| Additional therapies | No premium add-ons listed; fewer integrated coaching tools | Sermorelin peptide therapy offered as an add-on |
| Regulatory note | Compounded medications are not FDA approved finished products | Compounded medications are not FDA approved finished products |
What this means for patients
If your priority is the lowest advertised monthly cash price and rapid shipping after approval, the sources show Embody markets itself as the cost driven, no frills option with $69/month semaglutide and $119/month tirzepatide and free 1 to 2 day delivery. If you value nurse practitioner oversight, a LegitScript certified pharmacy network, and access to an additional peptide line like Sermorelin, Regenics is presented as the mid priced option with promotional first month pricing that renews higher.
Get Embody pricing and shipping details
Safety and limitations
Both providers offer compounded medications. The sources clearly note that compounded medications are not FDA approved finished products and are not reviewed by FDA for safety, effectiveness or quality. Regenics notes that treatment is available only when a licensed clinician determines it is medically appropriate. Final pricing may vary based on dose and clinician recommendation according to the Embody source. No claims about efficacy or insurance coverage beyond the supplied facts are made in the sources.
View Regenics clinician and pricing details
Conclusion: Choose based on price and priorities
Embody vs Regenics comes down to trade offs in price, clinician model, shipping, and add ons. Choose Embody if you want the lowest entry price and fastest shipping from the evidence provided. Choose Regenics if you prefer nurse practitioner oversight, a LegitScript certified pharmacy network, and access to Sermorelin as an add-on, accepting promotional first month pricing that renews higher.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →More comparisons
